Cargando…
How Long that a SARS-CoV-2 Variant Delay Impacts Required Period to Achieve Herd Immunity?
Autores principales: | Joob, Beuy, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580213/ https://www.ncbi.nlm.nih.gov/pubmed/37854986 http://dx.doi.org/10.4103/ijpvm.ijpvm_201_21 |
Ejemplares similares
-
Exposure history and molecular epidemiology of SARS-CoV-2: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2023) -
Effect of SARS-CoV-2 infection on trauma throughput to alternative elective care approaches
por: Joob, Beuy, et al.
Publicado: (2023) -
SARS-CoV-2 RT-PCR test, false result problem, public risk assessment and reliability of epidemiology statistics
por: Joob, Beuy, et al.
Publicado: (2020) -
New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
por: Joob, Beuy, et al.
Publicado: (2021) -
Aggressive Behavior and Short–Long Polymorphisms of Monoamine Oxidase A: An Example of Effect of Genetic Molecular Mass Change in Psychological Medicine
por: Joob, Beuy, et al.
Publicado: (2017)